Subscribe To
CGTX / Cognition Therapeutics, Inc. (CGTX) CEO Lisa Ricciardi on Q4 2021 Results - Earnings Call Transcript
Content Topics
Cognition
Therapeutics
Inc
CGTX
Lisa
Ricciardi
2021
Therapeutics
cgtx
Results
Earnings
Transcript
Stock
CGTX News
By Seeking Alpha
August 12, 2023
Cognition Therapeutics, Inc. (CGTX) Q2 2023 Earnings Call Transcript
Cognition Therapeutics, Inc. (NASDAQ:CGTX ) Q2 2023 Earnings Conference Call August 8, 2023 8:00 AM ET Company Participants Daniel Kontoh-Boateng - In more_horizontal
By GlobeNewsWire
June 27, 2023
Cognition Therapeutics to Host Call and Webcast to Discuss Topline Results from CT1812 Phase 2 SEQUEL Study on June 28, 2023
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage neuroscience company developing drugs that t more_horizontal
By GlobeNewsWire
March 21, 2023
Cognition Therapeutics to Present Proteomic Biomarker Analyses from Clinical Studies of CT1812 in Patients with Alzheimer's Disease at AD/PD 2023
- CEO Participating on Panel Hosted by Alzheimer's Drug Discovery Foundation - - CEO Participating on Panel Hosted by Alzheimer's Drug Discovery Found more_horizontal
By GlobeNewsWire
March 16, 2023
UPDATE – Cognition Therapeutics to Report Fourth Quarter and Full Year 2022 Results
Conference Call and Live Audio Webcast Scheduled for Thursday, March 23, 2023, 8:00 a.m. ET Conference Call and Live Audio Webcast Scheduled for Thurs more_horizontal
By GlobeNewsWire
May 4, 2022
CORRECTION -- Cognition Therapeutics to Report First Quarter 2022 Financial Results on May 11, 2022
PURCHASE, N.Y., May 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Cognition Therapeutics, Inc. (NASDAQ: CG more_horizontal
By Seeking Alpha
March 30, 2022
Cognition Therapeutics, Inc. (CGTX) CEO Lisa Ricciardi on Q4 2021 Results - Earnings Call Transcript
Cognition Therapeutics, Inc. (CGTX) CEO Lisa Ricciardi on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Market Watch
October 8, 2021
Cognition Therapeutics raised more than $45 million after IPO priced in the middle of the expected range
Cognition Therapeutics Inc.'s stock CGTX, is set to start trading Friday, after the New York-based biopharmaceutical company targeting treatments for more_horizontal
By Market Watch
October 8, 2021
Cognition Therapeutics raised more than $45 million after IPO priced in the middle of the expected range
Cognition Therapeutics Inc.'s stock CGTX, is set to start trading Friday, after the New York-based biopharmaceutical company targeting treatments for more_horizontal
